These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 7769101)
1. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. Theus SA; Andrews RP; Steele P; Walzer PD J Clin Invest; 1995 Jun; 95(6):2587-93. PubMed ID: 7769101 [TBL] [Abstract][Full Text] [Related]
2. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization. Smulian AG; Sullivan DW; Theus SA Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685 [TBL] [Abstract][Full Text] [Related]
3. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Theus SA; Smulian AG; Steele P; Linke MJ; Walzer PD Vaccine; 1998 Jul; 16(11-12):1149-57. PubMed ID: 9682373 [TBL] [Abstract][Full Text] [Related]
4. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. Theus SA; Andrews RP; Linke MJ; Walzer PD J Eukaryot Microbiol; 1997; 44(2):96-100. PubMed ID: 9109259 [TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of specific lymphocyte populations sensitized to the major surface glycoprotein of Pneumocystis carinii decreases organism burden while increasing survival rate in the rat. Theus SA; Walzer PD J Eukaryot Microbiol; 1997; 44(6):23S-24S. PubMed ID: 9508414 [No Abstract] [Full Text] [Related]
6. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Theus SA; Linke MJ; Andrews RP; Walzer PD Infect Immun; 1993 Nov; 61(11):4703-9. PubMed ID: 8406869 [TBL] [Abstract][Full Text] [Related]
7. Cytokine responses to the native and recombinant forms of the major surface glycoprotein of Pneumocystis carinii. Theus SA; Smulian AG; Sullivan DW; Walzer PD Clin Exp Immunol; 1997 Aug; 109(2):255-60. PubMed ID: 9276520 [TBL] [Abstract][Full Text] [Related]
8. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice. Bishop LR; Helman D; Kovacs JA BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748 [TBL] [Abstract][Full Text] [Related]
9. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. Roths JB; Sidman CL J Clin Invest; 1992 Aug; 90(2):673-8. PubMed ID: 1353767 [TBL] [Abstract][Full Text] [Related]
10. Recombinant major surface glycoprotein of Pneumocystis carinii elicits a specific immune response but is not protective in immunosuppressed rats. Lasbury ME; Angus CW; Klivington D; Durant PJ; Bartlett MS; Smith JW; Lee CH J Eukaryot Microbiol; 1999; 46(5):136S-137S. PubMed ID: 10519289 [No Abstract] [Full Text] [Related]
11. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region. Mei Q; Turner RE; Sorial V; Klivington D; Angus CW; Kovacs JA Infect Immun; 1998 Sep; 66(9):4268-73. PubMed ID: 9712777 [TBL] [Abstract][Full Text] [Related]
12. The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis. Benfield TL; Lundgren JD FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):129-34. PubMed ID: 9792071 [No Abstract] [Full Text] [Related]
13. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice. Gigliotti F; Garvy BA; Haidaris CG; Harmsen AG J Infect Dis; 1998 Jul; 178(1):235-42. PubMed ID: 9652446 [TBL] [Abstract][Full Text] [Related]
14. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection. Fisher DJ; Gigliotti F; Zauderer M; Harmsen AG Infect Immun; 1991 Oct; 59(10):3372-6. PubMed ID: 1894351 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the antigenic recognition of the major surface glycoprotein of Pneumocystis carinii isolated from different rat strains. Andrews RP; Theus SA; Cushion MT; Walzer PD J Eukaryot Microbiol; 1994; 41(5):72S. PubMed ID: 7804270 [No Abstract] [Full Text] [Related]
16. Western blot analysis of rat Pneumocystis carinii antigens using convalescent rat sera and rabbit anti-gp120. Pascale JM; Shaw MM; Bartlett MS; Smith JW; McLaughlin GL J Eukaryot Microbiol; 1996; 43(5):30S. PubMed ID: 8822834 [No Abstract] [Full Text] [Related]
17. Major surface glycoprotein genes from Pneumocystis carinii f. sp. ratti. Schaffzin JK; Garbe TR; Stringer JR Fungal Genet Biol; 1999 Dec; 28(3):214-26. PubMed ID: 10669586 [TBL] [Abstract][Full Text] [Related]
18. Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii. Wada M; Sunkin SM; Stringer JR; Nakamura Y J Infect Dis; 1995 Jun; 171(6):1563-8. PubMed ID: 7769293 [TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a major human Pneumocystis carinii surface antigen. Lundgren B; Lipschik GY; Kovacs JA J Clin Invest; 1991 Jan; 87(1):163-70. PubMed ID: 1985093 [TBL] [Abstract][Full Text] [Related]
20. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120). Fisher DJ; Gigliotti F; Zauderer M; Harmsen AG J Protozool; 1991; 38(6):22S-23S. PubMed ID: 1818177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]